arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Lyell Immunopharma, Inc.

LYEL Health Care Biotechnology: Pharmaceutical Preparations
$11.97
▼ -8.3% Today
as of Jun 7, 07:20 ET
Last 30 days -44.30% Apr 28 → Jun 05
$11.21 $13.97 $16.73 $19.49 $22.25 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$12.99
High
$13.51
Low
$11.70
Volume
$96,332
Avg Vol
$85,490
Mkt Cap
$393M
P/E (TTM)
Beta
52w High
$45.00
52w Low
$8.46
Div Yield
Shares Out
$23M

Overview

52-week range
$8.46
$45
10% of range
Avg surprise (last 2)
+32.8%
Avg reaction (last 2)
-1.5%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.59$-2.74$-1.89$-1.03$-0.18 Actual $-0.26Actual $-0.20Actual $-0.24Actual $-3.59Actual $-3.48Actual $-0.18Est $-0.19Actual $-2.89Actual $-2.13Actual $-1.10Est $-2.78 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-52M$-39M$-26M$-13M$35,700 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-1.10 $-2.78 +60.4% -511.1% +1.1% earnings
Tue Sep 30, 2025Sep 2025 $-2.13 financials
Mon Jun 30, 2025Jun 2025 $-2.89 financials
Tue May 13, 2025Mar/2025 $-0.18 $-0.19 +5.3% -4.0% earnings
Mon Sep 30, 2024Sep 2024 $-3.48 financials
Sun Jun 30, 2024Jun 2024 $-3.59 financials
Sun Mar 31, 2024Mar 2024 $-0.24 financials
Sat Sep 30, 2023Sep 2023 $-0.20 financials
Fri Jun 30, 2023Jun 2023 $-0.26 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$2,000$15,000$8,000$7,000$34,000$13,000
Cost of revenue
Gross profit
Operating income$-44M$-37M$-47M$-57M$-51M$-52M
Net income$-24M$-39M$-43M$-52M$-45M$-46M
EPS (diluted)$-1.10$-2.13$-2.89$-3.54$-3.48$-3.59

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$91M$60M$124M$99M$120M$106M$100M$133M
Inventory
Total current assets$267M$261M$328M$282M$309M$380M$450M$500M
Total assets$351M$340M$408M$385M$430M$491M$619M$654M
Long-term debt
Total liabilities$77M$92M$79M$87M$93M$108M$89M$88M
Total equity$274M$248M$329M$299M$337M$383M$531M$567M

Implied volatility — last 90 days

No IV snapshots yet for LYEL.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.